Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Clin Genitourin Cancer. 2022 Jan 7;20(3):296–296.e9. doi: 10.1016/j.clgc.2022.01.001

Table 2:

Univariable and Multivariable analysis of factors predicting PC use

Characteristics Univariate Multivariable
OR (95% CI) p-value OR (95% CI) p-value
Age
 Per year 0.999 [0.997, 1.001] 0.16 0.999 [0.996, 1.002] 0.52
Sex
 Male Ref Ref
 Female 1.01 [0.96, 1.06] 0.77 1.06 [0.996, 1.12] 0.07
Charlson-Deyo score
 0 Ref Ref
 1 1.02 [0.96, 1.08] 0.59 1.08 [1.01, 1.15] 0.03
 2+ 1.09 [0.99, 1.19] 0.06 1.16 [1.05, 1.28] <0.01
Race
 White Ref Ref
 Black 0.87 [0.8, 0.94] <0.01 0.91 [0.82, 1.002] 0.06
 Others 0.9 [0.78, 1.04] 0.16 1.12 [0.96, 1.32] 0.16
 Unknown 0.75 [0.57, 0.97] 0.03 0.83 [0.62, 1.11] 0.20
Insurance status
 Private Ref Ref
 Uninsured 1.07 [0.95, 1.2] 0.25 1.19 [1.05, 1.36] <0.01
 Medicaid 1.16 [1.05, 1.27] <0.01 1.18 [1.06, 1.31] <0.01
 Medicare 1.05 [0.99, 1.11] 0.09 1.09 [1.01, 1.17] 0.02
 Other Government 1.48 [1.22, 1.79] <0. 01 1.36 [1.09, 1.69] <0.01
 Unknown 0.75 [0.61, 0.92] <0.01 0.78 [0.62, 0.97] 0.03
Facility type
 Academic/Research program Ref Ref
 Community cancer program 1.06 [0.97, 1.16] 0.19 1.03 [0.94, 1.14] 0.49
 Comprehensive community cancer program 1.1 [1.04, 1.16] <0.01 1.11 [1.05, 1.19] <0.01
 Integrated network 1.09 [1.001, 1.19] 0.05 1.13 [1.02, 1.25] 0.02
Facility location
 South Atlantic Ref Ref
 New England 1.56 [1.39, 1.75] <0. 01 1.57 [1.38, 1.79] <0.01
 Middle Atlantic 1.17 [1.08, 1.27] <0. 01 1.3 [1.18, 1.43] <0.01
 East North Central 1.33 [1.23, 1.44] <0. 01 1.32 [1.21, 1.44] <0.01
 East South Central 1.07 [0.96, 1.19] 0.25 1.03 [0.91, 1.16] 0.66
 West North Central 1.23 [1.12, 1.36] <0. 01 1.16 [1.04, 1.3] <0.01
 West South Central 0.75 [0.68, 0.83] <0.01 0.78 [0.69, 0.87] <0.01
 Mountain 0.95 [0.83, 1.08] 0.43 0.89 [0.77, 1.02] 0.10
 Pacific 0.59 [0.53, 0.65] <0.01 0.55 [0.49, 0.62] <0.01
Income
 <$38,000 Ref Ref
 $38,000-$47,999 1.08 [1.001, 1.16] 0.05 0.94 [0.86, 1.02] 0.16
 $48,000-$62,999 1.03 [0.96, 1.11] 0.46 0.85 [0.77, 0.94] <0.01
 >$63,000 0.95 [0.88, 1.03] 0.20 0.76 [0.68, 0.85] <0.01
Education (% no high school degree)
 ≥ 21% Ref Ref
 13-20% 1.19 [1.11, 1.29] <0.01 1.12 [1.03, 1.23] <0.01
 7-12.9% 1.23 [1.14, 1.33] <0.01 1.17 [1.06, 1.29] <0.01
 <7% 1.2 [1.11, 1.3] <0.01 1.26 [1.12, 1.42] <0.01
Distance to Facility
 ≤ 4.7 miles Ref Ref
 4.8 – 11.2 miles 0.99 [0.93, 1.06] 0.86 1.02 [0.95, 1.1] 0.55
 11.3 – 29.5 miles 1.06 [0.99, 1.13] 0.10 1.06 [0.98, 1.15] 0.13
 > 29.5 miles 0.88 [0.82, 0.94] <0. 01 0.95 [0.88, 1.04] 0.26
Histology
 Clear cell Ref Ref
 Non-clear Cell 0.86 [0.78, 0.95] <0.01 1.11 [0.99, 1.24] 0.08
 Sarcomatoid 1.02 [0.92, 1.13] 0.66 1.17 [1.04, 1.31] <0.01
Year of Diagnosis
 2004-2007 Ref - Ref -
 2008 - 2010 0.997 [0.93, 1.07] 0.92 1.06 [0.98, 1.14] 0.15
 2011 - 2014 1.13 [1.06, 1.2] <0.01 1.21 [1.13, 1.3] <0.01
Clinical trial participation
 No Ref Ref
 Yes 0.51 [0.29, 0.91] 0.02 0.76 [0.41, 1.4] 0.379
Treatments
 None Ref Ref
 Surgery 0.45 [0.39, 0.51] <0.01 0.46 [0.4, 0.53] <0.01
 Radiation 6.64 [6.06, 7.27] <0.01 7 [6.36, 7.7] <0.01
 Systemic therapy 1.24 [1.14, 1.36] <0.01 1.25 [1.14, 1.38] <0.01
 Surgery + Radiation 3.82 [3.37, 4.34] <0.01 4 [3.5, 4.57] <0.01
 Surgery + Systemic 0.73 [0.65, 0.81] <0.01 0.75 [0.66, 0.84] <0.01
 Radiation + Systemic 6.2 [5.69, 6.75] <0.01 6.36 [5.8, 6.97] <0.01
 Surgery + Radiation + Systemic 4.6 [4.14, 5.11] <0.01 4.87 [4.34, 5.45] <0.01
 Unknown 0.96 [0.78, 1.19] 0.72 0.97 [0.78, 1.21] 0.81